Among them, the SIGLEC1 expression of female CRC patients was higher than that of male (p < 0.05) (Figure 2A), and there was a significant difference between the N1 and N2 stage (p < 0.05) (Figure 2B). Here, SIGLEC1 is linked to colorectal carcinoma.